Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
30 janv. 2023 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,” Company”, “GTG”), a global leader in guidance-driven genomics-based tests in health,...
Gene Editing Market Size Worth USD 19.4 Billion by 2030 at 14.7% CAGR – Report by Market Research Future (MRFR)
17 janv. 2023 09h30 HE
|
Market Research Future
New York, USA, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Gene Editing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Gene Editing Market Information By...
Gene Therapy Market Size to Surpass USD 3,251.92 Million by 2030 at 19.10% CAGR – Report by Market Research Future (MRFR)
02 janv. 2023 09h30 HE
|
Market Research Future
New York, USA, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Gene Therapy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), "Gene Therapy Market Information By...
Fraser Institute News Release: Canadian generosity hits lowest point in 20 years
15 déc. 2022 05h00 HE
|
Fraser Institute
VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The number of Canadians donating to charity—as a percentage of all tax filers—is at the lowest point in 20 years, finds a new study...
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
06 déc. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health,...
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
10 nov. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
09 nov. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
29 sept. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GENE Momentum building - a year in review
30 août 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene achieves key milestones and growth
28 juil. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...